Salubris Biotherapeutics picks up $32m
Salubris Biotherapeutics Inc, a clinical-stage biotechnology company, has secured $32 million in financing.
Salubris Biotherapeutics Inc, a clinical-stage biotechnology company, has secured $32 million in financing.
Copyright PEI Media
Not for publication, email or dissemination